Clinical Trials
62 trialsESPB
McMaster University
BIOSUNTOX
University Hospital, Rouen
Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response
Centre Oscar Lambret
NeuroPrevPTSD
Centre Oscar Lambret
EmFin-Nx
Jinling Hospital, China
Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma
Indiana University
Immune PDX
Duke University
Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer
University of Nebraska
Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery
University of Missouri-Columbia
IPAC
Centre Georges Francois Leclerc
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
City of Hope Medical Center
UW17104
University of Wisconsin, Madison
EMIR
Centre Hospitalier Universitaire de Besancon
Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer
Brown University
PrE0801
PrECOG, LLC.
The Use of Self Retaining Sutures in Open and Laparoscopic Partial Nephrectomy
Nova Scotia Health Authority
Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center
Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
Rutgers, The State University of New Jersey
Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
Masonic Cancer Center, University of Minnesota
Study of IL2 in Combination With Zoledronic Acid in Patients With Kidney Cancer
University of Wisconsin, Madison
Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Northwestern University
Conformal High Dose Intensity Modulated Radiation Therapy for Disease to Thoracic and Lumbar Spine
University of Kentucky
N1
CureOne
Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases
Alliance for Clinical Trials in Oncology
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Washington University School of Medicine
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
Medical University of South Carolina
PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
Medical University of South Carolina
NECPAR
Centre Hospitalier Universitaire de Saint Etienne
Microwave Coagulation in Partial Nephrectomy Protocol
University of Wisconsin, Madison
Interleukin-2 in Metastatic Kidney Cancer
Western Regional Medical Center
PREV
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
KCM201
University of Oxford
Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
Masonic Cancer Center, University of Minnesota
MT2004-30: Tomotherapy for Solid Tumors
Masonic Cancer Center, University of Minnesota
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
Masonic Cancer Center, University of Minnesota
Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer
Burzynski Research Institute
5-AZ
University of Kansas Medical Center
Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer
Wake Forest University Health Sciences
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)
Stanford University
Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma
Hellenic Cooperative Oncology Group
COG-ANGIO
Centre Francois Baclesse
Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal
Baylor College of Medicine
Safety Study of Specific Tumor Target Drug Plus Immune System Therapy in Patients With Kidney Cancer
The Methodist Hospital Research Institute
[18F]Fluciclatide PET Imaging of Pazopanib Response
Asan Medical Center
BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)
Memorial Sloan Kettering Cancer Center
POORTOR
Gustave Roussy, Cancer Campus, Grand Paris
Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
Medical University of South Carolina
Velcade and Sorafenib in Unresected or Metastatic Renal Cell Carcinoma
New Mexico Cancer Research Alliance
Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
Ohio State University Comprehensive Cancer Center
PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
Ohio State University Comprehensive Cancer Center